Thyroid autoimmunity

Endocrine Development

Volumn 26, Issue , 2014, Pages 139-157

  Wiersinga, Wilmar M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; IODINE; LEUKOCYTE ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; SELENIUM; THYROGLOBULIN; THYROID AUTOANTIGEN; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; IODIDE PEROXIDASE;

ADULT DISEASE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROID DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BACTERIAL INFECTION; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CHILDHOOD DISEASE; ENVIRONMENTAL FACTOR; GRAVES DISEASE; HEREDITY; HUMAN; IMMUNOLOGICAL SYNAPSE; IMMUNOPATHOGENESIS; SMOKING; T LYMPHOCYTE; THYROID DISEASE; YERSINIA ENTEROCOLITICA; GENETICS; IMMUNOLOGY;

AUTOIMMUNE DISEASES; HUMANS; IODIDE PEROXIDASE; RECEPTORS, THYROTROPIN; THYROGLOBULIN; THYROID DISEASES;

EID: 84958659377     PISSN: 14217082     EISSN: 16622979     Source Type: Book Series    
DOI: 10.1159/000363161     Document Type: Article

References (78)

1. Nabhan ZM, Kreher NC, Eugster EA: Hashitoxicosis in children: clinical features and natural history. J Pediatr 2005;146:533-536.
2. Tamai H, Kasagi K, Takaichi Y, Takamatsu J, Komaki G, Matsubayashi S, Konishi J, Kuma K, Kumagai LF, Nagataki S: Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroid drugs: clinical, immunological, and histological findings in 26 patients. J Clin Endocrinol Metab 1989;69:49-53.
3. Czarnocka B: Thyroperoxidase, thyroglobulin, Na (+)/I (-) symporter, pendrin in thyroid autoimmunity. Front Biosci 2011;16:783-802.
4. - symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD). J Clin Endocrinol Metab 2000;85:3937-3940.
5. Tonacchera M, Agretti P, Ceccarini G, Lenza R, Refetoff S, Santini F, Pinchera A, Chiovato L, Vitti P: Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. Eur J Endocrinol 2001;144:611-618.
6. Yoshida A, Hisatome I, Taniguchi S, Shirayoshi Y, Yamamoto Y, Miake J, Ohkura T, Akama T, Igawa O, Shigemasa C, Kamijo K, Ikuyama S, Caturegli P, Suzuki K: Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab 2009;94:442-448.
7. Kemp EH, Sandhu HK, Watson PF, Weetman AP: Low frequency of pendrin autoantibodies detected using a radioligand binding assay in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 2013;98:E309-E313.
8. Smith TJ: Is IGF-1 receptor a target for autoantibody generation in Graves' disease? J Clin Endocrinol Metab 2013;98:515-518.
9. Minich WB, Dehina N, Welsink T, Schwiebert C, Morgenthaler NG, Kohrle J, Eckstein A, Schomburg L: Autoantibodies to the IGF-1 receptor in Graves' orbitopathy. J Clin Endocrinol Metab 2013;98:752-760.
10. McLachlan SM, Rapoport B: Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev 2014;35:59-105.
11. McLachlan SM, Rapoport B: Thyroid peroxidase as an autoantigen. Thyroid 2007;17:939-948.
12. Rapoport B, McLachlan SM: The thyrotropin receptor in Graves' disease. Thyroid 2007;17:911-922.
13. Geenen V, Bodart G, Henry S, Michaux H, Dardenne O, Charlet-Renard C, Martens H, Hober D: Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunity. Front Neurosci 2013;7:187.
14. Perniola R, Filograna O, Greco G, Pellegrino V: High prevalence of thyroid autoimmunity in Apulian patients with autoimmune polyglandular syndrome type 1. Thyroid 2008;18:1027-1029.
15. Nithiyananthan R, Heward JM, Allahabadia A, Barnett AH, Franklyn JA, Cough S C L: A heterozygous deletion of the autoimmune regulator (AIRE1) gene, autoimmune thyroid disease, and type 1 diabetes: no evidence for association. J Clin Endocrinol Metabol 2000;85:1320-1322.
16. Meyer G, Donner H, Herwig J, Bohles H, Usadel KH, Badenhoop K: Screening for an AIRE-1 mutation in patients with Addison's disease, type 1 diabetes, Graves' disease and Hashimoto's thyroiditis as well as APECED syndrome. Clin Endocrinol 2001;54:335-338.
17. Weetman AP: Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 2003;148:1-9.
18. Brand OJ, Barrett JC, Simmonds MJ, Newby PR, McCabe CJ, Bruce CK, Kysela B, Carr-Smith JD, Brix T, Hunt PJ, et al: Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Hum Mol Gen 2009;18:1704-1713.
19. Colobran R, Armengol MP, Fauer R, Gartner M, Tykocinski LO, Lucas A, Ruiz M, Juan M, Kyewski B, Pujol-Borrell R: Association of an SNP with intrathymic transcription of TSHR and Graves' disease: a role for defective thymic tolerance. Hum Mol Genet 2011;20:3415-3423.
20. Jacobson EM, Tomer Y: The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 2007;28:85-98.
21. Ban Y, Tozaki T, Taniyama M, Skrabanek L, Nakano Y, Ban Y, Hirano T: Multiple SNPs in intron 41 of thyroglobulin gene are associated with autoimmune thyroid disease in the Japanese population. PLoS One 2012;7:e37501.
22. Hodge SE, Ban Y, Strug LJ, Greenberg DA, Davies TF, Concepcion ES, Villanueva R, Tomer Y: Possible interaction between HLA-DRβ1 and thyroglobulin variants in Graves' disease. Thyroid 2006;14:351-356.
23. Zhao S-X, Liu W, Zhan M, Song Z-Y, Yang S-Y, Xue L-Q, Pan C-M, Gu Z-H, Liu B-L, Wang H-N, et al: A refined study of FRCL genes from a genome-wide association study for Graves' disease. PLoS One 2013;8:e57758.
24. Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, Gough SC: Association of the interleukin-2 receptor alpha (IL-2R alpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol 2007;66:508-512.
25. Strieder T G A, Drexhage HA, Lam-Tse WK, Prummel MF, Tijssen J G P, Wiersinga WM: A reduced IL2R (CD25) expression level in first and second-degree female relatives of AITD patients. A sign of poor capability to preserve tolerance? Autoimmunity 2006;39:93-98.
26. Owen CJ, Eden JA, Jennings CE, Wilson V, Cheetham TD, Pearce SH: Genetic association studies of the FOXP3 gene in Graves' disease and autoimmune Addison's disease in the United Kingdom population. J Mol Endocrinol 2006;37:97-104.
27. Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES, Tomer Y: The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun 2007;28:201-207.
28. Chu X, Pan CM, Zhao SX, Liang J, Gao GQ, Zhang XM, Yuan GY, Li CG, Xue LQ, Shen M, et al: A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet 2011;43:897-901.
29. Bulow Pedersen I, Knudsen N, Carle A, Vejbjerg P, Jorgensen T, Perrild H, Ovesen L, Rasmussen BL, Laurberg P: A cautious iodization program bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clin Endocrinol 2011;75:120-126.
30. Pedersen IB, Laurberg P, Knudsen N, Jorgensen T, Perrild H, Ovesen L, Rasmussen LB: An increased incidence of overt hypothyroidism after iodine fortification of salt in Denmark: a prospective population study. J Clin Endocrinol Metab 2007;92:3122-3127.
31. Dogan M, Acikgoz E, Acikgoz M, Cesur Y, Ariyuca S, Bektas MS: The frequency of Hashimoto thyroiditis in children and the relationship between urinary iodine level and Hashimoto thyroiditis. J Pediatr Endocrinol Metab 2011;24:75-80.
32. Garcia-Garcia E, Vazquez-Lopez MA, Garcia-Fuentes E, Rodriquez-Sanchez FI, Munoz FJ, Bonillo-Perales A, Soriquer F: Iodine intake and prevalence of thyroid autoimmunity and autoimmune thyroiditis in children and adolescents aged between 1 and 16 years. Eur J Endocrinol 2012;167:387-392.
33. Rasooly L, Rose NR, Saboori AM, Ladenson PW, Burck CL: Iodine is essential for human T cell recognition of human thyroglobulin. Autoimmunity 1998;27:213-219.
34. Latrofa F, Fiore E, Rago T, Antonangeli L, Montanelli L, Ricci D, Provenzale MA, Scutari M, Frigeri M, Tonacchera M, Vitti P: Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. J Clin Endocrinol Metab 2013;98:e1768-e1774.
35. Wiersinga WM: Smoking and thyroid. Clin Endocrinol 2013;79:145-151.
36. Krassas GE, Segni M, Wiersinga WM: Childhood Graves' ophthalmopathy: results of a European questionnaire study. Eur J Endocrinol 2005;153:515-521.
37. Krassas GE, Wiersinga WM: Smoking and autoimmune thyroid disease: the plot thickens. Eur J Endocrinol 2006;154:777-780.
38. Wang Z, Zhang Q, Lu J, Jiang F, Zhang H, Gao L, Zhao J: Identification of outer membrane porin F protein of Yersinia enterocolitica recognized by antithyrotropin receptor antibodies in Graves' disease and determination of its epitope using mass spectrometry and bioinformatics tools. J Clin Endocrinol Metab 2010;95:4012-4020.
39. Hargreaves CE, Grasso M, Hampe CS, Stenkova A, Atkinson S, Joshua GW, Wren BW, Buckle AM, Dunn-Walters D, Banga P: Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease. J Immunol 2013;190:5373-5381.
40. Effraimidis G, Tijssen JG, Strieder TG, Wiersinga WM: No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study. Clin Exp Immunol 2011;165:38-43.
41. Tomer Y: Interferon induced thyroiditis. J Autoimmun 2010;34:J322-J326.
42. Blackard J, Kong L, Huber A, Tomer Y: Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of HCV and thyroiditis. Thyroid 2012;23:863-870.
43. Indolfi G, Stagi S, Bartolini E, Salti R, de Martino M, Azzari C, Resti M: Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection. Clin Endocrinol 2008;68:117-121.
44. Enouz S, Carrue L, Merkler D, Bevan MJ, Zehn D: Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection. J Exp Med 2012;209:1769-1779.
45. Eskes SA, Endert E, Fliers E, Birnie E, Hollenbach B, Schomburg L, Kohrle J, Wiersinga WM: Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin Endocrinol 2014;80:444-451.
46. Onal H, Keskindemirci G, Adal E, Ersen A, Korkmaz O: Effects of selenium supplementation in the early stage of autoimmune thyroiditis in childhood: an open-label study. J Pediatr Endocrinol Metab 2012;25:639-644.
47. Effraimidis G, Tijssen JG, Brosschot JF, Wiersinga WM: Involvement of stress in the pathogenesis of autoimmune thyroid disease: a prospective study. Psychoneuroendocrinology 2012;37:1191-1198.
48. Camurdan OM, Doger E, Bideci A, Celik N, Cinaz P: Vitamin D status in children with Hashimoto thyroiditis. J Pediatr Endocrinol Metab 2012;25:467-470.
49. Brix TH, Hegedus L: Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin Endocrinol 2012;76:457-464.
50. Beumer W, Effraimidis G, Drexhage RC, Wiersinga WM, Drexhage HA: Changes in serum adhesion molecules, chemokines, cytokines, and tissue remodeling factors in euthyroid women without thyroid antibodies who are at risk for autoimmune thyroid disease: a hypothesis on the early phases of the endocrine autoimmune reaction. J Clin Endocrinol Metab 2013;98:2460-2468.
51. Weetman AP: Chronic autoimmune thyroiditis; in Braverman LE, Cooper DS (ed): The Thyroid. A Fundamental and Clinical Text, ed 10. Philadelphia, Wolters/Kluwer, 2013, pp 525-534.
52. Morshed SA, Latif R, Davies TF: Delineating the autoimmune mechanisms in Graves' disease. Immunol Res 2012;54:191-203.
53. Lavard L, Ranlov I, Perrild H, Andersen O, Jacobsen BB: Incidence of juvenile thyrotoxicosis in Denmark, 1982-1988. A nationwide study. Eur J Endocrinol 1994;130:565-568.
54. Wong GW, Cheng PS: Increasing incidence of childhood Graves' disease in Hong Kong: a follow-up study. Clin Endocrinol 2001;54:547-550.
55. Barnes HV, Blizzard RM: Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolescents. J Pediatr 1977;91:313-320.
56. Vaidya VA, Bongiovanni AM, Parks JS, Tenore A, Kirkland RT: Twenty-two years' experience in the medical management of juvenile thyrotoxicosis. Pediatrics 1974;54:565-570.
57. Shulman DL, Muhar I, Jorgensen V, Diamond FB, Bercu BB, Root AW: Autoimmune hyperthyroidism in prepubertal children and adolescents: comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997;7:755-760.
58. Lazar L, Kalter-Leibovici O, Pertzelan A, Weintrob N, Josefsberg Z, Phillip M: Thyrotoxicosis in prepubertal children compared with pubertal and postpubertal children. J Clin Endocrinol Metab 2000;85:3678-3682.
59. Poyrazoglu S, Saka N, Bas F, Isguven P, Dogu A, Turan S, et al: Evaluation of diagnosis and treatment results in children with Graves' disease with emphasis on the puberal status of patients. J Pediatr Endocrinol Metab 2008;21:745-751.
60. Kaguelidou F, Alberti C, Castanet M, Guitteny M-A, Czernichow P, Leger J: Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment. J Clin Endocrinol Metab 2008;93:3817-3826.
61. Kaloumenou I, Mastorakos G, Alevizaki M, Duntas LH, Mantzou E, Ladopoulos C, Antoniou A, Chiotis D, Papassotiriou I, Chrousos GP, Dacou-Voutetakis C: Thyroid autoimmunity in schoolchildren in an area with long-standing iodine sufficiency: correlation with gender, pubertal stage, and maternal thyroid autoimmunity. Thyroid 2008;18:747-754.
62. 4, and thyroid antibodies in the Unites States population (1988-1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002;87:489-499.
63. Radetti G, Gottardi E, Bona G, Corrias A, Salardi S, Loche S, et al: The natural history of euthyroid Hashimoto's thyroiditis in children. J Pediatr 2006;149:827-832.
64. Demirbilek H, Kandemir N, Gonc EN, Ozon A, Alikasifoglu A, Yordam N: Hashimoto's thyroiditis in children and adolescents: a retrospective study on clinical, epidemiological and laboratory properties of the disease. J Pediatr Endocrinol Metab 2007;20:1199-1205.
65. Wasniewska M, Corrias A, Salerno M, Mussa A, Capalbo D, Messina MF, Aversa T, Bombaci S, De Luca F, Valenzise M: Thyroid function patterns at Hashimoto's thyroiditis presentation in childhood and adolescence are mainly conditioned by patient's age. Horm Res Paediatr 2012;78:232-236.
66. Yeo PP, Chan SH, Thai AC, Ng WY, Lui KF, Wee GB, Tan SH, Lee BW, Wong HB, Cheah JS: HLA Bw46 and DR9 associations in Graves' disease of Chinese patients are age- and sex-related. Tissue Antigens 1989;34:179-184.
67. ∗ 0501 with early-onset Graves' disease in Japanese. Hum Immunol 1994;39:195-201.
68. Farid NR, Stone E, Johnson G: Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol 1980;13:535-544.
69. ∗ 0201 haplotype. Tissue Antigens 1997;50:639-641.
70. Jurecka-Lubieniecka B, Ploski R, Kula D, Krol A, Bednarczuk T, Kolosza Z, Tukiendorf A, Szpak-Ulczok S, Stanjek-Cichoracka A, Polanska J, Jarzab B: Association between age at diagnosis of Graves' disease and variants in genes involved in immune response. PLoS One 2013;8:e59349.
71. Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Chatterjee VK, Lazarus JH, Pearce S H S, Vaidya B, Gough SC, Franklyn JA: Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab 2006;91:4873-4880.
72. Brix TH, Petersen HC, Iachine I, Hegedus L: Preliminary evidence of genetic anticipation in Graves' disease. Thyroid 2003;13:447-451.
73. Vos XG, Smit N, Endert E, Tijssen J G P, Wiersinga WM: Variation in phenotypic appearance of Graves' disease: effect of genetic anticipation and duration of complaints. Eur J Endocrinol 2009;161:113-118.
74. De Luca F, Corrias A, Salermo M, Wasniewska M, Gastaldi R, Cassio A, Mussa A, Aversa T, Radetti G, Arrigo T: Peculiarities of Graves' disease in children and adolescents with Down's syndrome. Eur J Endocrinol 2010;162:591-595.
75. Karlsson B, Gustafsson J, Hedov G, Ivarsson SA, Anneren G: Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 1998;79:242-245.
76. Jorgensen KT, Rostgaard K, Bache I, Bigger RJ, Nielsen NM, Tommerup N, Frisch M: Autoimmune diseases in women with Turner's syndrome. Arthritis Rheum 2010;62:658-666.
77. Effraimidis G, Wiersinga WM: Autoimmune thyroid disease: old and new players. Eur J Endocrinol 2014;170:R1-R13.
78. Vos XG, Endert E, Tijssen J G P, Wiersinga WM: Genotypes in relation to phenotypic appearance and exposure to environmental factors in Graves' hyperthyroidism. Eur J Endocrinol 2012;167:783-792.